GE Healthcare Shares Drop After Mixed Q1 Results

GE Healthcare (GEHC) reported mixed first-quarter results on Tuesday, with revenue and earnings slightly missing estimates. The company’s total revenue declined by 1% year over year to $4.65 billion, while adjusted earnings per share came in at $0.90, missing the consensus by 1 cent. Despite the disappointing results, GE Healthcare maintained its full-year guidance and expressed optimism about the business’s growth prospects. The market reacted negatively to the earnings, sending the stock down by nearly 14% in Tuesday’s trading session. However, analysts believe that the sell-off is an overreaction and that GEHC remains an attractive investment opportunity due to its strong market position and growth potential in areas such as Alzheimer’s disease diagnostics.

CNBC Investing Club’s Homestretch: April Ends on a Sour Note, Fed Rate Decision Looms

The stock market closed out April on a down note, breaking a five-month winning streak. The Dow Jones Industrial Average, S&P 500, and Nasdaq all posted losses, as did GE Healthcare, Constellation Brands, and Eaton. However, Eli Lilly shares rose after the drugmaker provided strong guidance. The Federal Reserve will announce its latest interest rate decision Wednesday afternoon, and Club members are encouraged to buy the dip in GE Healthcare and Eaton.

Scroll to Top